Christopher Burghuber

Author

Also Known As

C Burghuber, C K. Burghuber, C. Burghuber, C.K. Burghuber, Christoph Burghuber, Christopher Burghuber, Christopher K Burghuber, Christopher K. Burghuber

Publications

848

Citations

H-Index

Concepts

All Affiliations

Medical University of Vienna Emory University Duke Medical Center Korea Research Institute of Bioscience and Biotechnology Duke University

About

Christopher Burghuber is an author at Medical University of Vienna specializing in medicine, immunotherapy, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	329
2	Health Sciences	2	2	56
3	Business	1	1	29
4	Education	1	1	29
5	Engineering	1	1	19

Christopher Burghuber

Publications

749

Citations

H-Index

Page 1

	Year	Citations
Short-Term Induction Therapy with Anti-Thymocyte Globulin and Delayed Use of Calcineurin Inhibitors in Orthotopic Liver Transplantation Thomas Soliman, Hubert Hetz, Christopher Burghuber, Liver Transplantation Orthotopic Liver TransplantationPharmacotherapyImmunotherapyTranslational MedicineGraft Survival	2007	87
Humoral Compensation after Bortezomib Treatment of Allosensitized Recipients Jean Kwun, Christopher Burghuber, Miriam Manook, Journal of the American Society of Nephrology	2017	83
Steroid Pretreatment of Organ Donors to Prevent Postischemic Renal Allograft Failure Alexander Kainz, Julia Wilflingseder, Christa Mitterbauer, Annals of Internal Medicine	2010	78
Dual targeting: Combining costimulation blockade and bortezomib to permit kidney transplantation in sensitized recipients Christopher Burghuber, Miriam Manook, Brian Ezekian, American Journal of Transplantation Cell TherapyTransplantation MedicineImmunologyPharmacotherapyImmunotherapy	2018	72
Antibody-Mediated Rejection in Sensitized Nonhuman Primates: Modeling Human Biology Christopher Burghuber, Jean Kwun, E. Page, American Journal of Transplantation Humoral ResponseImmunologyTransplantation MedicineSkin TransplantationNonhuman Primates	2015	51
Successful desensitization with proteasome inhibition and costimulation blockade in sensitized nonhuman primates Jean Kwun, Christopher Burghuber, Miriam Manook, Blood Advances	2017	49
NGAL and MMP-9/NGAL as biomarkers of plaque vulnerability and targets of statins in patients with carotid atherosclerosis Wolf Eilenberg, Stefan Stojković, Alexandra Kaider, Clinical Chemistry and Laboratory Medicine (CCLM)	2017	46
Molecular adsorbent recirculating system in patients with early allograft dysfunction after liver transplantation: A pilot study Hubert Hetz, Peter Faybik, Gabriela Berlakovich, Liver Transplantation Solid Organ TransplantationImmunologyTransplantation MedicineMolecular AdsorbentBiomedical Engineering	2006	42
Modulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive value Anna Michlmayr, Thomas Bachleitner‐Hofmann, Suzann Baumann, British Journal of Cancer	2010	33
Plasma <scp>HMGB</scp>‐1 after the initial dose of epirubicin/docetaxel in cancer Tobias Arnold, Anna Michlmayr, Suzann Baumann, European Journal of Clinical Investigation	2013	31

Page 1